Celator Pharmaceuticals | About Celator: Board of Directors

Our Mission: Improving and Extending the Lives of Patients with Cancer

Management Board of Directors Scientific Advisory Board Investors Business Development Careers

Board of Directors

Joseph A. Mollica, Ph.D., Chairman, Celator Pharmaceuticals, Inc.; Chairman, Neurocrine Biosciences, Inc.

Patrick Brady, Growthworks Capital

J. Kevin Buchi, Executive Vice President and Chief Financial Officer, Cephalon, Inc.

Ken Galbraith, Ventures West Management

Brenda Gavin, D.V.M., M.B.A., Quaker BioVentures

Scott Jackson, R.Ph., M.B.A., Chief Executive Officer, Celator Pharmaceuticals, Inc.

Lawrence Mayer, Ph.D., President and Head of Research, Celator Pharmaceuticals, Inc.

Nicole Vitullo, M.B.A., Domain Associates L.L.C.

Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.